科学家发现两种癌症药物 可能会扭转老年痴呆症在小鼠身上的症状, 这是为人类试验准备的。 Scientists discover two cancer drugs may reverse Alzheimer's symptoms in mice, set for human trials.

科学家们发现，来曲唑和伊立替康这两种抗癌药物的组合可以通过逆转与阿尔茨海默病相关的大脑变化来帮助治疗阿尔茨海默病。 Scientists have found that a combination of two cancer drugs, letrozole and irinotecan, may help treat Alzheimer's disease by reversing brain changes associated with the condition. 在对小鼠的研究中,药物组合减少了大脑退化和改善记忆力。 In studies with mice, the drug combination reduced brain degeneration and improved memory. 这种发现可能导致老年痴呆症治疗的更快、更廉价的发展,因为这些药物已经由食品和药物管理局批准用于治疗癌症。 This discovery could lead to faster and cheaper development of treatments for Alzheimer's, as the drugs are already FDA-approved for cancer. 研究人员正计划在对阿尔茨海默氏病患者的临床试验中测试这些药物。 Researchers are planning to test these drugs in clinical trials with Alzheimer's patients.